General information, not an individual diagnosis. Ask a healthcare professional if you are unsure about your situation.
An oral corticosteroid can increase blood glucose even when prescribed for another condition. The cited MEDROL 16 mg leaflet states this and says the doctor may request blood tests. This medicine-related effect warrants clear instructions when the prescription starts.
The MEDROL product information explains that corticosteroids can worsen pre-existing diabetes. It also says diabetes does not automatically rule out corticosteroid treatment when it is necessary. Reporting diabetes lets the prescriber organise monitoring alongside the treatment’s expected benefit.
With antidiabetic treatment, the product information describes a possible rise in glucose and calls for increased self-monitoring, especially at the start of corticosteroid treatment. Any adjustment of medicines is the doctor’s responsibility; it cannot be inferred from a general corticosteroid rule.
Ameli explains that self-monitoring depends on the type of diabetes and treatment. The doctor specifies how often to measure and what to do with the results. Clarify what changes with the prescribed corticosteroid and which results or situations require contacting the doctor.
If self-monitoring is already prescribed, keep the results with the measurement time and context, as Ameli advises. Also tell the doctor when corticosteroid treatment began. These details help them assess changes without turning an isolated reading into a treatment decision.
The MEDROL product information says interaction with antidiabetic medicines may require medical adjustment during corticosteroid treatment and afterwards. Clarify how long to follow the glucose instructions and who will reassess the results. Do not invent a personal threshold or change a dose yourself.
Sources
Your health review
Review your health
Mon bilan prévention is an appointment to discuss your habits and choose your health priorities. Review the four age groups and practical information.